CSHS WWW HOME | MS EXCHANGE LOG ON | FEEDBACK
Medical Staff Pulse is
a Publication of the Chief of Staff
Research Corner
Stem Cells Cultured from Human Bone Marrow Behave Like Those Derived from Brain Tissue

Stem cells taken from adult human bone marrow have been manipulated by scientists at the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai to generate aggregates of cells called spheres that are similar to those derived from neural stem cells of the brain. In addition, the bone marrow-derived stem cells, which could be differentiated into neurons and other cells making up the central nervous system, spread far and wide and behaved like neural stem cells when transplanted into the brain tissue of chicken embryos.

Results of the experiments, described in the February 2007 issue of the Journal of Neuroscience Research, support the concept of using bone marrow-derived stem cells to create therapies to treat brain tumors, strokes and neurodegenerative diseases. A similar study using bone marrow-derived stem cells of rats appeared as the cover article in the December 2002 issue of Experimental Neurology.

"These findings reinforce the data that came from our study of rat bone marrow-derived stem cells," said John S. Yu, M.D., neurosurgeon, co-director of the Comprehensive Brain Tumor Program, and senior author of both articles. "Using two methods, we show evidence for the bone marrow-derived stem cells being neural cells, and we demonstrate that it is feasible to grow the cells in large numbers. We also document that these cells function electrophysiologically as neurons, using similar voltage-regulating mechanisms."

Progressing from the rat study to experiments with human cells and transplantation into mammal brain tissue, the research team continues to build a foundation for translating laboratory research into human clinical trials.

"Based on our studies to date, a patient's own bone marrow appears to offer a viable and renewable source of neural stem cells, allowing us to avoid many of the issues related to other types of stem cells," said Keith L. Black, M.D., chairman of Cedars-Sinai¿s Department of Neurosurgery and director of the Maxine Dunitz Neurosurgical Institute.

The study was supported by grants from the National Institutes of Health.